Darmopil, Sanja <br/><br/>
Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.  [electronic resource] 

 -  Biological psychiatry  Sep 2009 
 - 603-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2402 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2009.04.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Analysis of Variance<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Behavior, Animal--drug effects<br/>Corpus Striatum--pathology<br/>Disease Models, Animal<br/>Dynorphins--metabolism<br/>Dyskinesia, Drug-Induced--etiology<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Functional Laterality<br/>Gene Expression Regulation--drug effects<br/>Histones--metabolism<br/>Levodopa--adverse effects<br/>Mice<br/>Mice, Knockout<br/>Motor Activity--drug effects<br/>Neurons--drug effects<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-fos--metabolism<br/>Receptors, Dopamine D1--deficiency<br/>Receptors, Dopamine D2--deficiency<br/>Statistics as Topic<br/>Tyrosine 3-Monooxygenase--metabolism